Grus F H, Augustin A J, Sekundo W, Loeffler K
Universitäts-Augenklinik Mainz.
Klin Monbl Augenheilkd. 2000 Mar;216(3):165-71. doi: 10.1055/s-2000-10538.
Allopurinol shows beneficial effects in the systemic treatment of lens-induced uveitis. This is believed to be due to the reduction of oxidative tissue damage via a dose-dependent free radical scavenging ability and an immunomodulating effect. The purpose of this study was to investigate the immunological effects in experimental autoimmune uveitis after systemic treatment with allopurinol (AL) and steroids (STER).
31 male Lewis rats were immunized with crude retinal extract, Freund's Adjuvans and pertussis toxin. The rats were divided into four groups: healthy rats (BASIS, n = 3), experimental autoimmune-uveitis without therapy (EAU, n = 9), 50 mg/kg bw. allopurinol i.v. (ALSYS, n = 9), and 7.5 mg/kg bw. methylprednisolone i.v. (STSYS, n = 10). ALSYS and STSYS received five intravenous injections during the 2 weeks immunization period. The rats' sera were tested against Western Blots (WB) of electrophoretic separations of retinal proteins. Based on digital image analysis, an analysis of discriminance was performed.
The multivariate analysis of discriminance revealed a significance difference between the WBs of ALSYS and STSYS (p < 0.01) compared to EAU without therapy. The number and intensity of peaks in WBs were strongly reduced in the ALSYS group compared to EAU.
AL revealed a strong immunomodulating effect in the treatment of experimental autoimmune uveitis that is markedly stronger than that of steroids. Together with the antioxidative effect of allopurinol known from previous studies, this drug could be a new promising therapeutic approach in the treatment of uveitis.
别嘌醇在晶状体诱导性葡萄膜炎的全身治疗中显示出有益效果。据信这是由于其通过剂量依赖性自由基清除能力和免疫调节作用减少了氧化组织损伤。本研究的目的是调查别嘌醇(AL)和类固醇(STER)全身治疗后对实验性自身免疫性葡萄膜炎的免疫影响。
31只雄性Lewis大鼠用粗制视网膜提取物、弗氏佐剂和百日咳毒素进行免疫。大鼠被分为四组:健康大鼠(基础组,n = 3)、未经治疗的实验性自身免疫性葡萄膜炎组(EAU,n = 9)、50 mg/kg体重静脉注射别嘌醇组(ALSYS,n = 9)和7.5 mg/kg体重静脉注射甲基泼尼松龙组(STSYS,n = 10)。ALSYS组和STSYS组在2周免疫期内接受五次静脉注射。用大鼠血清检测视网膜蛋白电泳分离的蛋白质免疫印迹(WB)。基于数字图像分析进行判别分析。
判别分析的多变量分析显示,与未经治疗的EAU组相比,ALSYS组和STSYS组的WB之间存在显著差异(p < 0.01)。与EAU组相比,ALSYS组WB中峰的数量和强度明显减少。
AL在治疗实验性自身免疫性葡萄膜炎中显示出强大的免疫调节作用,明显强于类固醇。结合先前研究中已知的别嘌醇的抗氧化作用,这种药物可能是治疗葡萄膜炎的一种新的有前景的治疗方法。